시장보고서

상품코드

1605765

지속형 피하 인슐린 주입 시장 : 제품 유형별, 환자 유형별, 최종 용도별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Continuous Subcutaneous Insulin Infusion Market, By Product Type, By Patient Type, By End-use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: 2024년 11월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 388 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

지속형 피하 인슐린 주입 시장 규모는 2023년 42억 4,500만 달러로 2024년부터 2032년까지 연평균 9.89% 성장할 것으로 예상됩니다.

지속형 피하 인슐린 주입 시장 - 시장 역학

고급 인슐린 전달 장치에 대한 인식이 높아짐에 따라 시장 수요가 증가

지속형 피하 인슐린 주입(CSII) 시장은 당뇨병 유병률 증가와 고급 인슐린 전달에 대한 인식이 높아지면서 현재 1형 당뇨병 환자의 40%가 인슐린 펌프를 사용하고 있습니다. 그러나 높은 의료 비용과 제한된 접근성으로 인해 산업 성장에 걸림돌이 될 수 있습니다. 반면, AI와 IoT 혁신으로 펌프의 기능과 환자 경험을 개선할 수 있는 기회가 있으며, 인공 췌장 시스템의 발전으로 데이터 통합이 확대되고 혈당 조절을 개선할 수 있는 기회가 있습니다.

지속형 피하 인슐린 주입 시장 - 주요 인사이트

당사의 리서치 애널리스트가 공유한 분석에 따르면, 세계 시장은 예측 기간(2024-2032년) 동안 매년 약 9.89%의 CAGR로 성장할 것으로 추정됩니다.

제품 유형별로는 테더 펌프가 2023년 가장 큰 시장 점유율을 보일 것으로 예측됐습니다.

환자 유형별로는 유형 1이 2023년 주요 유형으로 부상했습니다.

지역별로는 2023년 북미가 주요 수익원이 되었습니다.

지속형 피하 인슐린 주입 시장 - 세분화 분석:

세계 지속형 피하 인슐린 주입 시장은 제품 유형, 환자 유형, 최종 용도 및 지역에 따라 세분화됩니다.

시장은 제품 유형에 따라 패치 펌프와 테더 펌프의 세 가지로 나뉩니다. 테더 펌프 분야가 시장을 독점하고 있습니다. 공기 대 공기 열 펌프는 유지보수가 거의 필요없고 설치가 간단합니다. 지반 공사가 필요없고 비용 효율적이기 때문에 지열 히트 펌프 시스템보다 더 많이 선택됩니다.

시장은 환자 유형에 따라 유형 1과 유형 2로 나뉩니다. 유형 1은 시장을 독점하고 있으며, 예측 기간 동안 그 우위를 유지할 것으로 보입니다. 주요 이유는 접근성과 휴대성이 뛰어나기 때문에 시장 점유율이 높기 때문입니다. 이 장치는 옷 아래 또는 옷 바깥쪽에 쉽게 착용할 수 있어 인슐린 관리의 편리함을 제공합니다.

지속형 피하 인슐린 주입 시장 - 지리적 인사이트

지역적으로 이 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카로 나뉩니다. 이 지역은 비즈니스를 가져오는 국가에 따라 더 세분화됩니다.

지속형 피하 인슐린 주입 시장 - 경쟁 상황:

세계 시장은 사용자 친화적인 기술과 혈당 조절 개선에 중점을 둔 첨단 인슐린 관리 솔루션의 채택 확대가 주도하고 있습니다. 시장 전략에는 혈당 모니터링 시스템과의 기기 통합을 강화하기 위한 제휴를 통해 실시간 데이터 및 예측 분석을 통해 사전 예방적 당뇨병 관리를 위한 실시간 데이터 및 예측 분석을 가능하게 하는 것이 포함됩니다. 또한, 각 업체들은 특히 다양한 계층의 1형 당뇨병 환자들을 위한 소형의 눈에 잘 띄지 않는 인슐린 펌프와 맞춤형 투약 옵션을 개발하여 환자들의 특정 요구를 충족시키는데 주력하고 있습니다.

소개
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아태평양
- 개요
- 아시아태평양의 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타

제11장 주요 벤더 분석 - 지속형 피하 인슐린 주입 업계

경쟁 대시보드
- Competitive Benchmarking
- Competitive Positioning
기업 개요
- Medtronic Inc.
- CeQur
- Tandem Diabetes Care
- F Hoffmann-La Roche
- Ypsomed
- Insulet Corporation
- Sooil Development
- Valeritas Inc.
- Cellenovo
- B. Braun Melsungen AG
- Bigfoot Biomedical, Inc.
- Becton, Dickinson and Company
- Fresenius SE &Co. KGaA
- MicroPort Scientific Corporation
- MannKind Corporation
- Nipro Corporation
- Shinmyung Mediyes CO., LTD.
- Sanofi SA
- Smiths Group PLC
- Others

제12장 애널리스트의 전방위 전망

ksm 24.12.20

REPORT HIGHLIGHT

Continuous subcutaneous insulin infusion market size was valued at USD 4,245 Million in 2023, expanding at a CAGR of 9.89% from 2024 to 2032.

Continuous subcutaneous insulin infusion (CSII) is a diabetes management method that uses an insulin pump to deliver small, continuous doses of rapid-acting insulin under the skin. This method mimics the body's natural insulin release, which helps in maintaining stable blood glucose levels. Patients can adjust doses for meals or exercise, offering flexibility and better glycemic control. CSII is especially beneficial for individuals with type 1 diabetes who require precise insulin regulation throughout the day and night.

Continuous Subcutaneous Insulin Infusion Market- Market Dynamics

Growing awareness about advanced insulin delivery devices to propel market demand

The continuous subcutaneous insulin infusion (CSII) market is driven by rising diabetes rates and increased awareness of advanced insulin delivery, with 40% of type 1 diabetes patients currently using insulin pumps. However, high healthcare costs and limited accessibility may hamper the industry's growth. On the contrary, Opportunities lie in AI and IoT innovations that enhance pump functionality and patient experience, alongside the advancement of artificial pancreas systems which promise expanded data integration and improved glucose control.

Continuous Subcutaneous Insulin Infusion Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.89% over the forecast period (2024-2032)

Based on product type segmentation, tethered pump was predicted to show maximum market share in the year 2023

Based on patient type segmentation, type 1 was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Continuous Subcutaneous Insulin Infusion Market- Segmentation Analysis:

The Global Continuous Subcutaneous Insulin Infusion Market is segmented based on Product Type, Patient Type, End-use, and Region.

The market is divided into three categories based on product type: patch pumps and tethered pumps. The tethered pumps sector dominates the market. The air-to-air heat pump requires very little maintenance and is simple to install. It is chosen over ground source heat pump systems since there are no groundwork costs and it is more cost-effective.

The market is divided into two categories based on patient type: type 1 and type 2. The type 1 sector dominates the market and is likely to maintain its dominance during the forecast period. This is majorly due to its accessibility and portability, capturing a significant market share. These devices, easily worn under or outside clothing, offer convenience for insulin management.

Continuous Subcutaneous Insulin Infusion Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Continuous Subcutaneous Insulin Infusion Market- Competitive Landscape:

The global market is driven by the growing adoption of advanced insulin management solutions, emphasizing user-friendly technology and improved glycemic control. Market strategies include partnerships to enhance device integration with glucose monitoring systems, enabling real-time data and predictive analytics for proactive diabetes management. Additionally, companies are focusing on developing compact, discreet insulin pumps and customizable dosing options to cater to specific patient needs, particularly in managing type 1 diabetes across diverse demographics.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Medtronic Inc.
CeQur
Tandem Diabetes Care
F Hoffmann-La Roche
Ypsomed
Insulet Corporation
Sooil Development
Valeritas Inc.
Cellenovo
B. Braun Melsungen AG
Bigfoot Biomedical, Inc.
Becton, Dickinson and Company
Fresenius SE & Co. KGaA
MicroPort Scientific Corporation
MannKind Corporation
Nipro Corporation
Shinmyung Mediyes CO., LTD.
Sanofi S.A.
Smiths Group PLC
Others

GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

Patch Pumps
Bolus
Basal
Basal & Bolus
Tethered Pumps
Battery
Insulin Set Insertion Devices
Insulin Reservoir & Cartridges

GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET, BY PATIENT TYPE- MARKET ANALYSIS, 2019 - 2032

Type 1
Type 2

GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032

Laboratories
Homecare
Hospitals

GLOBAL CONTINUOUS SUBCUTANEOUS INSULIN INFUSION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Continuous Subcutaneous Insulin Infusion Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Continuous Subcutaneous Insulin Infusion Market Snippet by Product Type
- 2.1.2. Continuous Subcutaneous Insulin Infusion Market Snippet by Patient Type
- 2.1.3. Continuous Subcutaneous Insulin Infusion Market Snippet by End-use
- 2.1.4. Continuous Subcutaneous Insulin Infusion Market Snippet by Country
- 2.1.5. Continuous Subcutaneous Insulin Infusion Market Snippet by Region
2.2. Competitive Insights

3. Continuous Subcutaneous Insulin Infusion Key Market Trends

3.1. Continuous Subcutaneous Insulin Infusion Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Continuous Subcutaneous Insulin Infusion Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Continuous Subcutaneous Insulin Infusion Market Opportunities
3.4. Continuous Subcutaneous Insulin Infusion Market Future Trends

4. Continuous Subcutaneous Insulin Infusion Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Continuous Subcutaneous Insulin Infusion Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Continuous Subcutaneous Insulin Infusion Market Landscape

6.1. Continuous Subcutaneous Insulin Infusion Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Continuous Subcutaneous Insulin Infusion Market - By Product Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
- 7.1.2. Patch Pumps
  - 7.1.2.1. Basal & Bolus
  - 7.1.2.2. Basal
  - 7.1.2.3. Bolus
- 7.1.3. Tethered Pumps
  - 7.1.3.1. Battery
  - 7.1.3.2. Insulin Set Insertion Devices
  - 7.1.3.3. Insulin Reservoir & Cartridges

8. Continuous Subcutaneous Insulin Infusion Market - By Patient Type

8.1. Overview
- 8.1.1. Segment Share Analysis, By Patient Type, 2023 & 2032 (%)
- 8.1.2. Type 1
- 8.1.3. Type 2

9. Continuous Subcutaneous Insulin Infusion Market - By End-use

9.1. Overview
- 9.1.1. Segment Share Analysis, By End-use, 2023 & 2032 (%)
- 9.1.2. Laboratories
- 9.1.3. Homecare
- 9.1.4. Hospitals

10. Continuous Subcutaneous Insulin Infusion Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Continuous Subcutaneous Insulin Infusion Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Continuous Subcutaneous Insulin Infusion Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.3.8. Italy
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.8.4. Italy Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.3.8.5. Italy Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.3.9. United Kingdom
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.9.4. United Kingdom Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.3.9.5. United Kingdom Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.3.10. France
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.10.4. France Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.3.10.5. France Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.3.11. Russia
  - 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.11.3. Russia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.3.11.4. Russia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.3.12. Netherlands
  - 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.12.3. Netherlands Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.3.12.4. Netherlands Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.3.14. Poland
  - 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.14.3. Poland Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.3.14.4. Poland Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.3.15. Rest of Europe
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.15.4. Rest of the Europe Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Continuous Subcutaneous Insulin Infusion Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.4.7. India
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.7.4. India Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.4.7.5. India Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.4.8. China
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.8.4. China Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.4.8.5. China Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.12.4. Thailand Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.4.12.5. Thailand Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.13.4. Indonesia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.4.13.5. Indonesia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Continuous Subcutaneous Insulin Infusion Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Continuous Subcutaneous Insulin Infusion Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.8.4. United Arab Emirates Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Continuous Subcutaneous Insulin Infusion Industry

11.1. Competitive Dashboard
- 11.1.1. Competitive Benchmarking
- 11.1.2. Competitive Positioning
11.2. Company Profiles
- 11.2.1. Medtronic Inc.
- 11.2.2. CeQur
- 11.2.3. Tandem Diabetes Care
- 11.2.4. F Hoffmann-La Roche
- 11.2.5. Ypsomed
- 11.2.6. Insulet Corporation
- 11.2.7. Sooil Development
- 11.2.8. Valeritas Inc.
- 11.2.9. Cellenovo
- 11.2.10. B. Braun Melsungen AG
- 11.2.11. Bigfoot Biomedical, Inc.
- 11.2.12. Becton, Dickinson and Company
- 11.2.13. Fresenius SE & Co. KGaA
- 11.2.14. MicroPort Scientific Corporation
- 11.2.15. MannKind Corporation
- 11.2.16. Nipro Corporation
- 11.2.17. Shinmyung Mediyes CO., LTD.
- 11.2.18. Sanofi S.A.
- 11.2.19. Smiths Group PLC
- 11.2.20. Others

12. 360 Degree Analyst View

13. Appendix

13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us